MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Serum Leptin levels in Iranian patients with Parkinson’s disease

    M. Salari, M. Etemadifar, M. Barzegar (Tehran, Islamic Republic of Iran)

    Objective: Parkinson’s disease (PD) is the second most common neurodegenerative disorder that frequently affects elderly population worldwide. Initially, PD was known as a motor disorder…
  • 2018 International Congress

    Microbiota DNA in the blood of patients with Parkinson’s disease

    S.Q. Xu, Y.W. Qian, X.D. Yang, S.D. Chen, Q. Xiao (Shanghai, China)

    Objective: The aim of this study was to explore the blood microbiota compositions in Chinese patients with Parkinson’s disease (PD). Background: Emerging evidences suggest that…
  • 2018 International Congress

    Catecholamines interrelation in plasma of early diagnosed treatment-naive patients with Parkinson disease

    D. Khasanova, Z. Zalyalova, M. Ugrumov (Kazan, Russian Federation)

    Objective: To investigate the interrelation of catecholamines in the blood plasma of healthy people and PD patients. Background: The study “START-1” was funded by Investment…
  • 2018 International Congress

    Unraveling gut microbiota in Parkinson’s disease and atypical parkinsonism

    R. Cilia, M. Barichella, M. Severgnini, E. Cassani, C. Bolliri, S. Caronni, V. Ferri, R. Cancello, S. Faierman, G. Pinelli, C. Ceccarani, G. De Bellis, L. Zecca, E. Cereda, C. Consolandi, G. Pezzoli (Milan, Italy)

    Objective: (1) To evaluate the differences in gut microbiota among Parkinson’s disease (PD), atypical parkinsonism (i.e. multiple system atrophy [MSA] and progressive supranuclear palsy [PSP])…
  • 2018 International Congress

    Spatiotemporal patterns of direct and indirect pathway striatal projection neurons in mouse model of Parkinson’s disease and dyskinesia

    C. Alcacer, M. Mendonca, A. Klaus, MA. Cenci, R. Costa (Lisbon, Portugal)

    Objective: To identify patterns of striatal projection neurons (SPN) activities that code for akinetic and dyskinetic movement disorders in a mouse model of hemiparkinsonism and…
  • 2018 International Congress

    Interaction of TDP-43 with IAPP in pancreatic beta cells of patients with sinucleinopathies

    R. Valenti-Azcarate, I. Martinez-Valbuena, C. Arean-Cuns, I. Marcilla-García, L. Alonso-Herrero, M. Carmona-Abellan, G. Marti-Andres, MT. Tuñon-Alvarez, MR. Luquin Piudo (Pamplona, Spain)

    Objective: We have investigated whether deposits of phosphorylated TDP-43 might be present in pancreatic tissue of patients with synucleinopathies. Background: The TAR DNA binding protein…
  • 2018 International Congress

    Bmal1 deficiency aggravates MPTP-induced dopaminergic cell death through promoting neuroinflammation

    C. Gu, W. Liu, X. Gu, F. Wang, Y. Yang, C. Liu (Su Zhou, China)

    Objective: Bmal1 is one of the most important central clock genes of circadian rhythm. Circadian rhythm dysfunction is one of the non-motor symptoms in Parkinson’s…
  • 2018 International Congress

    Characterization of the preclinical model parkinQ311X

    A. Ciammola, M. Regoni, D. Mercatelli, L. Croci, G. Serratto, S. Fasano, L. Murru, S. Novello, M. Pingue, V. Silani, G. Consalez, F. Valtorta, M. Passafaro, M. Morari, J. Sassone (Milan, Italy)

    Objective: To characterize the preclinical model parkinQ311X. Because the PARK2-associated disease in humans is characterized by juvenile onset and slow progression, in order to clarify…
  • 2018 International Congress

    Neuroprotection effects of probiotics strains on a chronic MPTP-induced mouse model of Parkinson’s disease

    Y. Qian, X. Yang, S. Xu, Q. Xiao (Shanghai, China)

    Objective: To explore the effects of probiotics strains on the neuroinflammation and degeneration of dopaminergic neurons in chronic Parkinson’s disease (PD) mice model. Background: Microglia-mediated…
  • 2018 International Congress

    Tau and α-synuclein autoantibodies as potential biomarkers for Parkinson’s and Alzheimer’s diseases

    A. Shalash, M. Salama, M. Makar, T. Roushdy, M. El-Balkimy (Cairo, Egypt)

    Objective: To investigate the value of the naturally occurring serum AIAs of α-synuclein (α-syn) and tau, proteins as potential biomarker for diagnosis of PD in…
  • « Previous Page
  • 1
  • …
  • 1568
  • 1569
  • 1570
  • 1571
  • 1572
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley